Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-688
Closed -$5K 1402
2020
Q3
$5K Sell
688
-1,966
-74% -$18.9K ﹤0.01% 2082
2020
Q2
$25K Sell
2,654
-12,424
-82% -$114K ﹤0.01% 1503
2020
Q1
$507K Hold
15,078
﹤0.01% 908
2019
Q4
$507K Buy
15,078
+11,345
+304% +$309K ﹤0.01% 908
2019
Q3
$100 Buy
3,733
+583
+19% +$17K ﹤0.01% 1405
2019
Q2
$104 Sell
3,150
-546
-15% -$19.8K ﹤0.01% 1383
2019
Q1
$150 Sell
3,696
-3,660
-50% -$135K ﹤0.01% 1278
2018
Q4
$197 Buy
7,356
+287
+4% +$10.6K ﹤0.01% 1125
2018
Q3
$307K Buy
7,069
+35
+0.5% +$1.47K ﹤0.01% 1011
2018
Q2
$294K Buy
+7,034
New +$288K ﹤0.01% 960

Other funds holding CHX

Glenmede Trust's CHX Position: Q4 2020 in Review

Glenmede Trust sold out of ChampionX (CHX) in Q4 2020, closing a stake of 688 shares — an estimated $5K sold.

Glenmede Trust first reported a position in CHX in Q2 2018 and held it in 10 quarters. The position peaked at $507K in Q1 2020. 301 funds tracked by Wall St. Rank hold CHX as of Q4 2020.

  • Glenmede Trust reported no remaining ChampionX position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 688 ChampionX shares in Q4 2020, an estimated $5K.
  • Glenmede Trust first reported a position in ChampionX in Q2 2018 and held it in 10 quarters.
  • Glenmede Trust's ChampionX position peaked at $507K in Q1 2020.
  • 301 funds tracked by Wall St. Rank held ChampionX as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.